Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Vaccine symbols : Tnxp save search
Tonix Pharmaceuticals’ Vaccine Candidate, TNX-1800, Selected by NIH/NIAID Project NextGen for Inclusion in Clinical Trials
Published: 2023-11-02 (Crawled : 12:00) - globenewswire.com
TNXP | $0.159 1.27% 620K
|
Health Technology
|
| O: 4.1%
H: 0.0%
C: -1.96%
tnx-1800 vaccine nextgen trials
Tonix Pharmaceuticals Presents Data from its Horsepox-Based Vaccine Development Platform at the World Vaccine Congress Europe
Published: 2023-10-19 (Crawled : 11:00) - globenewswire.com
TNXP | $0.159 1.27% 620K
|
Health Technology
|
| O: -0.02%
H: 0.87%
C: -1.77%
europe vaccine congress world pharmaceuticals platform
Tonix Pharmaceuticals Announces Oral Presentation at the World Vaccine Congress Europe
Published: 2023-10-11 (Crawled : 11:00) - globenewswire.com
TNXP | $0.159 1.27% 620K
|
Health Technology
|
| O: -0.54%
H: 4.61%
C: 2.55%
europe vaccine congress world presentation pharmaceuticals
Tonix Pharmaceuticals Announces Results of Pre-IND Meeting with FDA for TNX-801 as a Potential Vaccine to Prevent Mpox and Smallpox
Published: 2023-08-21 (Crawled : 11:00) - globenewswire.com
TNXP | $0.159 1.27% 620K
|
Health Technology
|
| O: 1.68%
H: 0.0%
C: 0.0%
tnx-801 fda vaccine pharmaceuticals smallpox meeting potential results
Tonix Pharmaceuticals Presents Data from its Vaccine Development Program at the World Vaccine Congress
Published: 2023-04-06 (Crawled : 23:00) - globenewswire.com
TNXP | $0.159 1.27% 620K
|
Health Technology
| Email alert
Add to watchlist
vaccine pharmaceuticals program
Tonix Pharmaceuticals Announces Oral Presentations at the World Vaccine Congress
Published: 2023-03-27 (Crawled : 20:00) - globenewswire.com
TNXP | $0.159 1.27% 620K
|
Health Technology
|
| O: 3.02%
H: 0.91%
C: -5.82%
vaccine pharmaceuticals
Tonix Pharmaceuticals Announces Publication of Paper in Viruses Highlighting the Company’s Development of a Vaccine to Protect Against Monkeypox and Smallpox (TNX-801)
Published: 2023-02-09 (Crawled : 13:00) - biospace.com/
TNXP | $0.159 1.27% 620K
|
Health Technology
|
| O: 1.63%
H: 1.6%
C: -11.2%
tnx-801 pharmaceuticals monkeypox smallpox vaccine publication
Tonix Pharmaceuticals Presents Development Update on Potential Smallpox and Monkeypox Vaccine TNX-801 in an Oral Presentation at the World Vaccine and Immunotherapy Congress
Published: 2022-12-01 (Crawled : 12:00) - globenewswire.com
TNXP | $0.159 1.27% 620K
|
Health Technology
|
| O: -1.3%
H: 2.76%
C: -0.26%
tnx-801 pharmaceuticals monkeypox smallpox immunotherapy vaccine presentation potential update
Tonix Pharmaceuticals Announces Oral Presentation at the World Vaccine and Immunotherapy Congress
Published: 2022-11-22 (Crawled : 13:20) - biospace.com/
TNXP | $0.159 1.27% 620K
|
Health Technology
|
| O: 1.21%
H: 1.26%
C: -0.03%
pharmaceuticals immunotherapy vaccine presentation
Tonix Pharmaceuticals Announces Collaboration with Kenya Medical Research Institute to Develop TNX-801 in Kenya as a Vaccine for the Prevention of Monkeypox and Smallpox Infection
Published: 2022-07-28 (Crawled : 15:00) - biospace.com/
TNXP | $0.159 1.27% 620K
|
Health Technology
|
| O: 5.62%
H: 11.83%
C: 10.65%
tnx-801 monkeypox smallpox research collaboration vaccine infection
Tonix Pharmaceuticals Announces Ribbon-Cutting Ceremony for its Advanced Development Center (ADC) for Vaccine Programs in Massachusetts
Published: 2022-06-16 (Crawled : 21:00) - biospace.com/
TNXP | $0.159 1.27% 620K
|
Health Technology
|
| O: -2.81%
H: 1.16%
C: -2.31%
vaccine
Tonix Pharmaceuticals Announces Presentation on TNX-801 Vaccine Protection Against Monkeypox at the 4th Symposium of the Canadian Society for Virology
Published: 2022-06-08 (Crawled : 12:20) - globenewswire.com
TNXP | $0.159 1.27% 620K
|
Health Technology
|
| O: -0.44%
H: 4.4%
C: 0.0%
tnx-801 monkeypox vaccine symposium presentation
Tonix Pharmaceuticals Announces Issuance of U.S. Patent for TNX-801 Smallpox and Monkeypox Vaccine and Recombinant Pox Virus (RPV) Platform Technology
Published: 2022-06-01 (Crawled : 02:00) - globenewswire.com
TNXP | $0.159 1.27% 620K
|
Health Technology
|
| O: 45.9%
H: 0.0%
C: 0.0%
tnx-801 monkeypox patent smallpox vaccine technology virus platform
Tonix Pharmaceuticals Announces Extension of Sponsored Research Agreement with Kansas State University to Develop Live-Virus Vaccine Against COVID-19
Published: 2022-04-05 (Crawled : 08:00) - globenewswire.com
TNXP | $0.159 1.27% 620K
|
Health Technology
|
| O: 0.35%
H: 0.0%
C: -5.23%
covid-19 research vaccine state
Tonix Pharmaceuticals Announces Exclusive Option and Research Collaboration with Kansas State University to Develop LNP-Free mRNA Vaccines
Published: 2022-01-04 (Crawled : 23:00) - biospace.com/
TNXP | $0.159 1.27% 620K
|
Health Technology
|
| O: 3.81%
H: 0.0%
C: 0.0%
als research collaboration vaccine
Tonix Pharmaceuticals Expands Research Collaboration to Develop Precision Medicine Techniques for COVID-19 Vaccines and Therapeutics
Published: 2021-09-23 (Crawled : 12:00) - biospace.com/
TNXP | $0.159 1.27% 620K
|
Health Technology
|
| O: 1.2%
H: 3.83%
C: 2.84%
covid collaboration vaccine research covid-19
Tonix Pharmaceuticals Announces Results of Pre-IND Meeting with FDA for TNX-1800 as a Potential Vaccine to Prevent COVID-19
Published: 2021-09-13 (Crawled : 12:15) - globenewswire.com
TNXP | $0.159 1.27% 620K
|
Health Technology
|
| O: 3.05%
H: 1.38%
C: -3.69%
covid fda potential results vaccine
Tonix Pharmaceuticals Announces Groundbreaking Ceremony for Massachusetts R&D Facility to House the Advanced Development Center (ADC) for Vaccine Programs
Published: 2021-08-02 (Crawled : 11:00) - globenewswire.com
TNXP | $0.159 1.27% 620K
|
Health Technology
|
| O: 0.83%
H: 1.34%
C: -1.63%
vaccine
Tonix Pharmaceuticals Announces Agreement to Acquire Infectious Disease R&D Facility to Accelerate Development of Vaccines and Antiviral Drugs
Published: 2021-07-27 (Crawled : 12:00) - biospace.com/
TNXP | $0.159 1.27% 620K
|
Health Technology
|
| O: 9.52%
H: 0.38%
C: -4.81%
disease infectious disease antiviral vaccine drug
Tonix Pharmaceuticals Reports Positive COVID-19 Vaccine Efficacy Results in Non-Human Primates Vaccinated with TNX-1800 and Challenged with Live SARS-CoV-2
Published: 2021-03-17 (Crawled : 12:30) - biospace.com/
TNXP | $0.159 1.27% 620K
|
Health Technology
|
| O: 13.39%
H: 10.42%
C: 4.17%
covid positive results vaccine sars-cov-2
Gainers vs Losers
| 76% | 24% |
Top 10 Gainers
AGBA | News | $1.22 205.0% 86M
|
Finance
EGOX | $0.054 50.0% 290M
|
CHRO | $1.66 35.51% 70K
|
n/a
INDO | $5.43 33.09% 10M
|
Energy Minerals
NVFY | $2.71 28.44% 31M
|
Consumer Durables
ZCMD | $1.86 28.28% 29M
|
Commercial Services
RWOD | $10.08 26.05% 5.6M
|
n/a
HUSA 4 | $2.07 23.95% 2.1M
|
Energy Minerals
TPET | $0.4001 22.02% 35M
|
n/a
SRFM 4 | $0.6 21.29% 850K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.